Shivakoti, Rupak http://orcid.org/0000-0002-2773-9310
,
Gupte, Nikhil
Tripathy, Srikanth
Poongulali, Selvamuthu
Kanyama, Cecilia
Berendes, Sima
Cardoso, Sandra W.
Santos, Breno R.
La Rosa, Alberto
Mwelase, Noluthando
Pillay, Sandy
Samaneka, Wadzanai
Riviere, Cynthia
Sugandhavesa, Patcharaphan
Bollinger, Robert C.
Balagopal, Ashwin
Semba, Richard D.
Christian, Parul
Campbell, Thomas B.
Gupta, Amita
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (R01 AI080417, UM1 AI068634, UM1 AI068636, UM1 AI106701, UM1 AI069465)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (K99 HD089753)
Article History
Received: 31 January 2018
Accepted: 9 August 2018
First Online: 24 September 2018
Ethics approval and consent to participate
: Ethics committees and institutional review boards from Johns Hopkins University (JHU) and participating site institutions approved this study. This study utilized bio-banked samples from individuals who had originally consented to the use of samples for future research.
: This manuscript only discusses analyses from de-identified data.
: Thomas B. Campbell is an advisory board member for Gilead Sciences and Theratechnologies, Inc. Amita Gupta and Rupak Shivakoti have received grant funding from Gilead Foundation. All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.